Institutional Ownership Fate Therapeutics Inc (FATE)
This table provides information about the institutional ownership of Fate Therapeutics Inc (FATE). We have compiled data on the 149 institutions that hold shares in the stock, with a total of 83.4 Million shares, which have been reported (via 13F filing form) to have a value of $78.4 Million.
| Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
|---|---|---|---|---|---|
|
Redmile Group, LLC
San Francisco, CA |
Aug 14, 2025 Q2 2025 |
12,872,946
shares
|
$12.1 Million
1.75% of portfolio
|
Q4 2024
Reduced 2.25%
|
|
|
Black Rock Inc.
New York, NY |
Aug 13, 2024 Q2 2024 |
10,116,106
shares
|
$9.51 Million
0.0% of portfolio
|
Q2 2024
Added 11.17%
|
|
|
Vanguard Group Inc
Valley Forge, PA |
Aug 11, 2025 Q2 2025 |
8,766,764
shares
|
$8.24 Million
0.0% of portfolio
|
Q2 2025
Reduced 14.97%
|
|
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
Aug 14, 2025 Q2 2025 |
4,543,867
shares
|
$4.27 Million
0.0% of portfolio
|
Q2 2025
Added 5.94%
|
|
|
Jpmorgan Chase & CO
New York, NY |
May 12, 2025 Q1 2025 |
3,398,283
shares
|
$3.19 Million
0.0% of portfolio
|
Q1 2025
Added 103.54%
|
|
|
Johnson & Johnson
New Brunswick, NJ |
Jul 22, 2025 Q2 2025 |
3,379,064
shares
|
$3.18 Million
1.27% of portfolio
|
Q3 2021
New holding
|
|
|
Vestal Point Capital, LP
New York, NY |
Aug 14, 2025 Q2 2025 |
2,515,000
shares
|
$2.36 Million
0.15% of portfolio
|
Q2 2025
Reduced 0.03%
|
|
|
Goldman Sachs Group Inc
New York, NY |
Aug 14, 2025 Q2 2025 |
2,511,676
shares
|
$2.36 Million
0.0% of portfolio
|
Q2 2025
Added 2.14%
|
|
|
Baker Bros. Advisors LP
New York, NY |
Aug 14, 2025 Q2 2025 |
2,485,018
shares
|
$2.34 Million
0.03% of portfolio
|
Q2 2025
Reduced 23.74%
|
|
|
Acadian Asset Management LLC
Boston, MA |
Aug 07, 2025 Q2 2025 |
2,459,954
shares
|
$2.31 Million
0.01% of portfolio
|
Q2 2025
Reduced 0.55%
|
|
|
Dimensional Fund Advisors LP
Austin, TX |
Aug 12, 2025 Q2 2025 |
2,437,729
shares
|
$2.29 Million
0.0% of portfolio
|
Q2 2025
Reduced 5.94%
|
|
|
Morgan Stanley
New York, NY |
Aug 15, 2025 Q2 2025 |
2,433,575
shares
|
$2.29 Million
0.0% of portfolio
|
Q2 2025
Added 8.64%
|
|
|
Geode Capital Management, LLC
Boston, MA |
Aug 08, 2025 Q2 2025 |
2,429,167
shares
|
$2.28 Million
0.0% of portfolio
|
Q2 2025
Added 7.03%
|
|
|
State Street Corp
Boston, MA |
Aug 14, 2025 Q2 2025 |
2,229,121
shares
|
$2.1 Million
0.0% of portfolio
|
Q2 2025
Added 5.64%
|
|
|
Citigroup Inc
|
Aug 11, 2025 Q2 2025 |
1,903,738
shares
|
$1.79 Million
0.0% of portfolio
|
Q2 2025
Reduced 1.72%
|
|
|
Tang Capital Management LLC
San Diego, CA |
Aug 14, 2025 Q2 2025 |
1,867,773
shares
|
$1.76 Million
0.13% of portfolio
|
Q1 2025
Added 0.64%
|
|
|
Jacobs Levy Equity Management, Inc
Florham Park, NJ |
Aug 14, 2025 Q2 2025 |
1,213,736
shares
|
$1.14 Million
0.01% of portfolio
|
Q2 2025
Reduced 44.91%
|
|
|
Pictet Asset Management Sa
Geneva 73, V8 |
Aug 10, 2023 Q2 2023 |
1,090,260
shares
|
$1.02 Million
0.01% of portfolio
|
Q2 2023
Reduced 9.09%
|
|
|
Ubs Group Ag
|
Aug 14, 2025 Q2 2025 |
962,672
shares
|
$904,911
0.0% of portfolio
|
Q2 2025
Reduced 37.94%
|
|
|
Schonfeld Strategic Advisors LLC
New York, NY |
Aug 14, 2025 Q2 2025 |
930,809
shares
|
$874,960
0.01% of portfolio
|
Q2 2025
Reduced 88.06%
|
|
|
Israel Englander
Millennium Management LLC | New York, Ny
|
Aug 14, 2025 Q2 2025 |
879,688
shares
|
$826,906
0.0% of portfolio
|
Q2 2025
Added 179.38%
|
|
|
Aqr Capital Management LLC
Greenwich, CT |
Aug 14, 2025 Q2 2025 |
846,233
shares
|
$795,459
0.0% of portfolio
|
Q2 2025
Added 44.65%
|
|
|
Northern Trust Corp
Chicago, IL |
Aug 13, 2025 Q2 2025 |
844,350
shares
|
$793,689
0.0% of portfolio
|
Q2 2025
Added 6.21%
|
|
|
Charles Schwab Investment Management Inc
San Francisco, CA |
Aug 12, 2025 Q2 2025 |
733,911
shares
|
$689,876
0.0% of portfolio
|
Q2 2025
Added 4.27%
|
|
|
Woodline Partners LP
San Francisco, CA |
Aug 14, 2025 Q2 2025 |
712,650
shares
|
$669,891
0.0% of portfolio
|
Q2 2025
Reduced 49.96%
|